Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 12, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	109	156	242	188	935	191	Upgrade
Market Cap Growth	13.41%	-35.59%	28.84%	-79.93%	389.63%	699.31%	Upgrade
Enterprise Value	105	152	207	131	880	177	Upgrade
Last Close Price	0.36	0.73	1.17	0.95	4.94	1.75	Upgrade
PE Ratio	-	5.13	-	-	-	-	Upgrade
PS Ratio	-	-	-	48.71	539.92	-	Upgrade
PB Ratio	0.82	1.54	3.93	2.65	13.89	8.51	Upgrade
P/TBV Ratio	0.82	1.54	3.93	2.65	13.89	8.51	Upgrade
EV/Sales Ratio	-	-	-	33.93	508.02	-	Upgrade
Asset Turnover	-	-	-	0.03	0.03	-	Upgrade
Quick Ratio	4.55	0.57	0.50	0.70	1.53	3.56	Upgrade
Current Ratio	4.81	0.69	0.67	0.90	1.54	3.61	Upgrade
Return on Equity (ROE)	-13.53%	58.39%	-	-57.98%	-462.88%	-41.08%	Upgrade
Return on Assets (ROA)	-7.86%	-8.03%	-	-16.01%	-24.72%	-23.37%	Upgrade
Return on Capital (ROIC)	-8.08%	-12.08%	-	-28.73%	-35.72%	-24.75%	Upgrade
Earnings Yield	-13.94%	19.49%	-17.84%	-20.68%	-22.26%	-3.07%	Upgrade
FCF Yield	-31.54%	-21.34%	-23.87%	-17.36%	-4.00%	-9.14%	Upgrade
Buyback Yield / Dilution	-17.05%	-4.17%	-0.27%	-20.99%	-95.75%	-232.97%	Upgrade

Updated Nov 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.